Showing results (281-290 of 447) with videos related to

Sort By:
Pageof 45
Cephalalgia : an International Journal of Headache|June 9, 2016
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraineTiffini Voss, Richard B Lipton, David W Dodick, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 21, 2019
Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysisPeter J Goadsby, David W Dodick, James M Martinez, et al.
Cephalalgia : an International Journal of Headache|November 4, 2020
Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraineDavid W Dodick, Erin G Doty, Sheena K Aurora, et al.
Headache|August 15, 2019
Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment StudyRichard B Lipton, Sagar Munjal, Dawn C Buse, et al.
The Journal of Headache and Pain|September 29, 2022
Exploring the neurobiology of the premonitory phase of migraine preclinically - a role for hypothalamic kappa opioid receptors?Caroline M Kopruszinski, Robson Vizin, Moe Watanabe, et al.
Cephalalgia : an International Journal of Headache|February 9, 2019
Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) studyDavid W Dodick, Michael L Reed, Kristina M Fanning, et al.
Pageof 45